| |
| |
|
| Insider
Information: |
Boess Carsten |
| Relationship: |
Director |
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
125,791 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,856,471 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
125,791 |
|
|
| Total
Value |
$5,856,471 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
Former CFO |
2005-06-27 |
5,000 |
2005-03-09 |
0 |
Premium* |
|
|
Insulet Corp |
PODD |
Vice President, Intern... |
2011-04-25 |
18,941 |
2007-12-03 |
0 |
Premium* |
|
|
Synageva BioPharma Corp |
GEVA |
SVP, Chief Financial O... |
2015-06-22 |
0 |
2012-07-18 |
0 |
Premium* |
|
|
Kiniksa Pharmaceuticals, Ltd. |
KNSA |
10% Owner |
2018-05-29 |
79,589 |
2018-05-29 |
0 |
Premium* |
|
|
Orchestra BioMed Holdings Inc. |
OBIO |
Director |
2020-08-03 |
22,261 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
66 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
Vice President & CFO |
• – – |
2005-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
|
- |
|
| PODD |
Insulet Corp |
Vice President, International |
• – – |
2010-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
33,240 |
0 |
- |
|
| PODD |
Insulet Corp |
Vice President, International |
• – – |
2011-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
20,000 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
SVP, Chief Financial Officer |
• – – |
2015-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
24,000 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
10% Owner |
– – • |
2018-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
6,392 |
79,589 |
0 |
- |
|
| PODD |
Insulet Corp |
Chief Financial Officer |
• – – |
2007-12-03 |
4 |
AS |
$23.63 |
$213,684 |
D/D |
(8,930) |
8,810 |
0 |
- |
|
| PODD |
Insulet Corp |
Chief Financial Officer |
• – – |
2007-12-03 |
4 |
AS |
$24.39 |
$179,272 |
D/D |
(7,260) |
17,740 |
0 |
- |
|
| PODD |
Insulet Corp |
Chief Financial Officer |
• – – |
2007-12-03 |
4 |
AS |
$23.50 |
$207,534 |
D/D |
(8,810) |
0 |
0 |
- |
|
| PODD |
Insulet Corp |
Chief Financial Officer |
• – – |
2007-12-04 |
4 |
AS |
$25.00 |
$55,000 |
D/D |
(2,200) |
0 |
0 |
- |
|
| PODD |
Insulet Corp |
Chief Financial Officer |
• – – |
2007-12-05 |
4 |
AS |
$25.00 |
$178,825 |
D/D |
(7,153) |
0 |
0 |
- |
|
| PODD |
Insulet Corp |
Vice President, International |
• – – |
2010-10-05 |
4 |
AS |
$15.03 |
$349,204 |
D/D |
(23,240) |
10,000 |
0 |
- |
|
| PODD |
Insulet Corp |
Vice President, International |
• – – |
2011-01-18 |
4 |
AS |
$17.50 |
$182,490 |
D/D |
(10,428) |
10,000 |
0 |
- |
|
| PODD |
Insulet Corp |
Vice President, International |
• – – |
2011-02-02 |
4 |
AS |
$17.51 |
$556,931 |
D/D |
(31,813) |
10,000 |
0 |
- |
|
| PODD |
Insulet Corp |
Vice President, International |
• – – |
2011-02-07 |
4 |
AS |
$17.50 |
$88,480 |
D/D |
(5,056) |
10,000 |
0 |
- |
|
| PODD |
Insulet Corp |
Vice President, International |
• – – |
2011-03-24 |
4 |
AS |
$19.51 |
$612,423 |
D/D |
(31,396) |
18,941 |
0 |
- |
|
| PODD |
Insulet Corp |
Vice President, International |
• – – |
2011-03-25 |
4 |
AS |
$19.76 |
$314,256 |
D/D |
(15,900) |
18,941 |
0 |
- |
|
| PODD |
Insulet Corp |
Vice President, International |
• – – |
2011-03-29 |
4 |
AS |
$20.52 |
$726,425 |
D/D |
(35,396) |
18,941 |
0 |
- |
|
| PODD |
Insulet Corp |
Vice President, International |
• – – |
2011-03-30 |
4 |
AS |
$20.67 |
$245,946 |
D/D |
(11,900) |
18,941 |
0 |
- |
|
| PODD |
Insulet Corp |
Vice President, International |
• – – |
2011-04-18 |
4 |
AS |
$21.50 |
$129,000 |
D/D |
(6,000) |
18,941 |
0 |
- |
|
| PODD |
Insulet Corp |
Vice President, International |
• – – |
2011-04-25 |
4 |
AS |
$21.54 |
$889,702 |
D/D |
(41,296) |
18,941 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
SVP, Chief Financial Officer |
• – – |
2012-07-18 |
4 |
AS |
$48.82 |
$323,091 |
D/D |
(6,618) |
0 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
SVP, Chief Financial Officer |
• – – |
2012-10-16 |
4 |
AS |
$49.88 |
$497,650 |
D/D |
(9,927) |
0 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
SVP, Chief Financial Officer |
• – – |
2013-01-16 |
4 |
AS |
$49.12 |
$487,614 |
D/D |
(9,927) |
0 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
SVP, Chief Financial Officer |
• – – |
2013-07-11 |
4 |
AS |
$47.06 |
$622,933 |
D/D |
(13,237) |
0 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
SVP, Chief Financial Officer |
• – – |
2013-08-16 |
4 |
AS |
$47.47 |
$204,121 |
D/D |
(4,300) |
0 |
0 |
- |
|
66 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
